Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)
Stock · NYSE · Consumer Discretionary
$10.13as of 10/16/2026
Price chart
Active signals
HLN Signal Track Record
How signals performed across all stocks →What HLN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| 200-Day Moving Average TouchActive now | 33 | +0.1% | 58% | September 3, 2026 |
| Volume Spike | 22 | +0.1% | 55% | September 15, 2026 |
| Bollinger Band Breakdown | 20 | +1.1% | 55% | October 1, 2026 |
| Bollinger Band BreakoutActive now | 17 | +0.4% | 53% | July 28, 2026 |
| Any 20-session window (baseline) | +0.4% | 54% |
Computed by MarketWall from daily closing prices since May 9, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HLN
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals,…
- Sector
- Consumer Discretionary
- Industry
- Package Goods/Cosmetics
- Employees
- 24,535
- Website
- www.haleon.com/
Fundamentals
- 1-day range
- $9.91$10.06
- Market cap
- $44.67B
- P/E (trailing)
- 19.62
- P/E (forward)
- 16.10
- EPS (trailing)
- $0.18
- Dividend yield
- 1.26%
- Beta
- 0.70
- Avg. volume
- 14.52M
- Ex-dividend date
- August 14, 2026
- Dividend pay date
- September 17, 2026
Forecasts
5 analyst ratings
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) Competitors
Chosen by industry and closest market cap.
- HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)$10.13▲ 1.91%Market cap $44.67BP/E 19.62$317.9$416.1
- KVUEKenvue Inc. Common Stock$18.91▲ 1.29%Market cap $36.83BP/E 20.57$14.02$20.13
- ELEstee Lauder Companies Inc. (The) Common Stock$104.54▼ 2.47%Market cap $30.93BP/E 205.30$66.22$121.64
- CHDChurch & Dwight Company Inc. Common Stock$104.53▲ 1.41%Market cap $24.52BP/E 32.23$81.33$106.04
- CLColgate-Palmolive Company Common Stock$94.11▲ 1.55%Market cap $74.14BP/E 35.97$74.55$99.33
- ECLEcolab Inc. Common Stock$288.89▼ 0.66%Market cap $79.78BP/E 37.91$243.15$309.27
- ELFe.l.f. Beauty Inc. Common Stock$113.54▼ 2.21%Market cap $5.49BP/E 106.33$48.82$141.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HLN Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | $44.67B | 19.62 | $10.13 | ▲ 1.91% | $317.9$416.1 |
| KVUE Kenvue Inc. Common Stock | $36.83B | 20.57 | $18.91 | ▲ 1.29% | $14.02$20.13 |
| EL Estee Lauder Companies Inc. (The) Common Stock | $30.93B | 205.30 | $104.54 | ▼ 2.47% | $66.22$121.64 |
| CHD Church & Dwight Company Inc. Common Stock | $24.52B | 32.23 | $104.53 | ▲ 1.41% | $81.33$106.04 |
| CL Colgate-Palmolive Company Common Stock | $74.14B | 35.97 | $94.11 | ▲ 1.55% | $74.55$99.33 |
| ECL Ecolab Inc. Common Stock | $79.78B | 37.91 | $288.89 | ▼ 0.66% | $243.15$309.27 |
| ELF e.l.f. Beauty Inc. Common Stock | $5.49B | 106.33 | $113.54 | ▼ 2.21% | $48.82$141.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Buy Any Of 15 Ideal 'Safer' October Dogs Tenured Over 10 YearsSeekingAlpha · 10/9/2026
- Goldman Sachs Top European Stock Picks Have a Hidden Perk for Income InvestorsYahoo · 10/5/2026
- 3 British AI Healthcare Stocks With Revenue Up To £61 BillionYahoo · 10/3/2026
- LCUT vs. HLN: Which Stock Is the Better Value Option?Yahoo · 9/28/2026
- J.P. Morgan flags negative catalyst at Haleon on weak sales momentumYahoo · 9/28/2026
- Haleon tipped to cut sales growth guidance as cough and cold season clouds outlookYahoo · 9/25/2026
- 3 British AI Stocks With Revenue Up To £61 BillionYahoo · 9/24/2026
- Haleon is Buying Better Shelf Space, Can the Visibility Help it Against Procter & Gamble and Colgate-Palmolive?Yahoo · 9/24/2026
- Sensodyne Maker Haleon Leverages Eye-Level Shelf Placement To Outpace Rivals-Reportbenzinga · 9/4/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 559.62M
- Total value held
- $5.40B
- Institutional holders
- 619
- Unknown146.54M
- Unknown113.97M
- Unknown31.72M
- Unknown19.17M
- Unknown15.71M
- Unknown15.03M
- Unknown14.67M
- Unknown10.93M
- Unknown9.20M
- Unknown9.09M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HLN launches nostalgic Excedrin campaign, analysts note valuation gap
Haleon has begun a new Excedrin marketing push that uses nostalgic digital‑pet themes to engage consumers. The effort aims to reinforce the brand’s moat and address a valuation gap highlighted by analysts. Haleon also appears on a list of British AI‑healthcare stocks that posted revenue growth of 4% or more this year. The stock is currently near the top of its 52‑week range.
HLN launches nostalgic Excedrin campaign, analysts note valuation gap. Haleon has begun a new Excedrin marketing push that uses nostalgic digital‑pet themes to engage consumers. The effort aims to reinforce the brand’s moat and address a valuation gap highlighted by analysts. Haleon also appears on a list of British AI‑healthcare stocks that posted revenue growth of 4% or more this year. The stock is currently near the top of its 52‑week range.